The role of NOS3 in stem cell mobilization

Trends in Molecular Medicine

Volumn 10, Issue 9, 2004, Pages 421-425

  Aicher, Alexandra ^a   Heeschen, Christopher ^a   Dimmeler, Stefanie ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; ROSUVASTATIN; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

ANGIOGENESIS; BONE MARROW; BONE MARROW SUPPRESSION; CARDIOVASCULAR DISEASE; CELL GROWTH; CELL INTERACTION; ENZYME ACTIVATION; EXERCISE; HUMAN; IN VITRO STUDY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; STEM CELL; STEM CELL MOBILIZATION; STROMA CELL;

EID: 4444337393     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2004.07.007     Document Type: Article

References (54)

1. S. Rafii, and D. Lyden Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration Nat. Med. 9 2003 702 712
2. J.M. Isner, and D.W. Losordo Therapeutic angiogenesis for heart failure Nat. Med. 5 1999 491 492
3. J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat. Med. 1 1995 27 31
4. T. Asahara Isolation of putative progenitor endothelial cells for angiogenesis Science 275 1997 964 967
5. T. Takahashi Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization Nat. Med. 5 1999 434 438
6. Q. Shi Evidence for circulating bone marrow-derived endothelial cells Blood 92 1998 362 367
7. P. Carmeliet Mechanisms of angiogenesis and arteriogenesis Nat. Med. 6 2000 389 395
8. U.M. Gehling In vitro differentiation of endothelial cells from AC133-positive progenitor cells Blood 95 2000 3106 3112
9. C. Kalka Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization Proc. Natl. Acad. Sci. U. S. A. 97 2000 3422 3427
10. B Fernandez Pujol Endothelial-like cells derived from human CD14 positive monocytes Differentiation 65 2000 287 300
11. S. Dimmeler HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway J. Clin. Invest. 108 2001 391 397
12. M. Vasa Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease Circulation 103 2001 2885 2890
13. A. Aicher Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells Nat. Med. 9 2003 1370 1376
14. S. Shintani Augmentation of postnatal neovascularization with autologous bone marrow transplantation Circulation 103 2001 897 903
15. A.A. Kocher Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function Nat. Med. 7 2001 430 436
16. B.E. Strauer Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
17. B. Assmus Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI) Circulation 106 2002 3009 3017
18. E. Tateishi-Yuyama Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial Lancet 360 2002 427 435
19. T. Asahara VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells EMBO J 18 1999 3964 3972
20. A.T. Askari Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy Lancet 362 2003 697 703
21. S.J. Morrison Regulatory mechanisms in stem cell biology Cell 88 1997 287 298
22. L.M. Calvi Osteoblastic cells regulate the haematopoietic stem cell niche Nature 425 2003 841 846
23. J. Zhang Identification of the haematopoietic stem cell niche and control of the niche size Nature 425 2003 836 841
24. T. Lapidot, and I. Petit Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells Exp. Hematol. 30 2002 973 981
25. J.P. Levesque Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor Blood 98 2001 1289 1297
26. J.P. Levesque Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide J. Clin. Invest. 111 2003 187 196
27. B. Heissig Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand Cell 109 2002 625 637
28. + stem cells from bone-marrow microenvironment Nat. Med. 8 2002 841 849
29. K. Hattori Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells Blood 97 2001 3354 3360
30. S.N. Robinson Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor cell mobilization or engraftment Stem Cells 21 2003 417 427
31. J.P. Levesque Characterization of hematopoietic progenitor mobilization in protease deficient mice Blood 104 2004 65 72
32. M. De Palma Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells Nat. Med. 9 2003 789 795
33. S. Moncada, and A. Higgs The L-arginine-nitric oxide pathway N. Engl. J. Med. 329 1993 2002 2012
34. T. Murohara Nitric oxide synthase modulates angiogenesis in response to tissue ischemia J. Clin. Invest. 101 1998 2567 2578
35. P.J. Shami, and J.B. Weinberg Differential effects of nitric oxide on erythroid and myeloid colony growth from CD34+ human bone marrow cells Blood 87 1996 977 982
36. U. Laufs Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis Circulation 109 2004 220 226
37. A. Iwakura Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury Circulation 108 2003 3115 3121
38. F. Prosper Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of α4 β1 integrin expression and function J. Clin. Invest. 101 1998 2456 2467
39. S. Hiratsuka MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis Cancer Cell 2 2002 289 300
40. Z. Gu S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death Science 297 2002 1186 1190
41. A.K. Death Nitroglycerin upregulates matrix metalloproteinase expression by human macrophages J. Am. Coll. Cardiol. 39 2002 1943 1950
42. M.V. Gurjar eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity Arterioscler. Thromb. Vasc. Biol. 19 1999 2871 2877
43. S. Dimmeler Activation of nitric oxide synthase in endothelial cells via Akt-dependent phosphorylation Nature 399 1999 601 605
44. R. Hambrecht Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase Circulation 107 2003 3152 3158
45. C. Urbich Double-edged role of statins in angiogenesis signaling Circ. Res. 90 2002 737 744
46. U. Laufs Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors Circulation 97 1998 1129 1135
47. J. Llevadot HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells J. Clin. Invest. 108 2001 399 405
48. J. Aguirre Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity Am. J. Pathol. 158 2001 247 257
49. G.G. Schwartz Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial J. Am. Med. Assoc. 285 2001 1711 1718
50. V. Schachinger Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
51. A.M. Zeiher Endothelial vasodilator dysfunction: pathogenetic link to myocardial ischaemia or epiphenomenon? Lancet 348 1996 S10 S12
52. M. Vasa Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circ. Res. 89 2001 E1 E7
53. O.M. Tepper Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures Circulation 106 2002 2781 2786
54. J.M. Hill Circulating endothelial progenitor cells, vascular function, and cardiovascular risk N. Engl. J. Med. 348 2003 593 600